Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

ESPRESPR
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in ESPERION THERAPEUTICS INC NE

BNP PARIBAS FINANCIAL MARKETS holds 42,801 shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $135,251 as of 2026-Q2. The position was decreased (-71.9% shares).

Current Value

$135,251

Current Shares

42,801

Total Value Change

-$68,248

Total Shares Change

-80,532

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
42,801
-71.9%
$135,2510.0%$3.16
0
2026-Q1
Decreased
152,340
-28.7%
$417,4120.0%$2.91
0
2025-Q4
Decreased
213,665
-40.2%
$790,5600.0%$3.69
0
2025-Q3
Increased
357,358
+1483.4%
$946,9990.0%$2.64
40
2025-Q2
Decreased
22,569
-91.7%
$22,2170.0%$0.99
0
2025-Q1
Increased
271,611
+77.3%
$391,1200.0%$1.50
36
2024-Q4
Increased
153,212
+24.2%
$337,0660.0%$2.15
29
2024-Q3
Increased
123,333
+152.7%
$203,4990.0%$1.68
37

Other major holders of ESPR: Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used